GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Additional Paid-In Capital

Organon Pharma Indonesia PT (ISX:SCPI) Additional Paid-In Capital : Rp0.00 Mil(As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Additional Paid-In Capital?



Organon Pharma Indonesia PT Additional Paid-In Capital Historical Data

The historical data trend for Organon Pharma Indonesia PT's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Additional Paid-In Capital Chart

Organon Pharma Indonesia PT Annual Data
Trend
Additional Paid-In Capital

Organon Pharma Indonesia PT Quarterly Data
Additional Paid-In Capital

Organon Pharma Indonesia PT Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Organon Pharma Indonesia PT Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines